Call toll-free 800.328.1267
Everyone's focused on tariffs and the global economy. But another potential risk may be emerging: worsening price action in the health-care sector. Key companies in the SPDR Health Care ETF (XLV) have tried to rally on good news lately, but failed. For example:...
Market Insights has covered the split between the new winners and losers in technology. Something similar seems to be underway in the health-care sector. Drug makers whose products offer the promise of growth have led. These includes biotechnology stocks, which keep...